title: Nurses must report adverse  drug reactions.
abstract: There is renewed determination throughout the European Union (EU) to reduce the economic cost and high death rate associated with adverse drug reactions through better pharmacovigilance. Timely reporting and sharing of information concerning adverse drug reactions is vital to the success of this initiative. In the UK, the reporting of serious adverse drug reactions is facilitated by the Yellow Card Scheme, yet despite being well placed to monitor the effect of medicines on patients, nurses do not make full use of the scheme. This article sets out the impact of adverse drug reactions in the EU and argues that it is essential that nurses must be at the vanguard of adverse reaction reporting if the EU's pharmacovigilance initiative is to be a success.
authors.affiliation: College of Human and Health Sciences, Swansea University.
authors.forename: Richard
authors.initials: R
authors.lastname: Griffith
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000331:legislation & jurisprudence*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000451:nursing*; D006801:Humans; D019221:Mandatory Reporting; D009740:Nursing Staff / Q000331:legislation & jurisprudence*; D017751:Safety Management; D006113:United Kingdom